$LPCN News

Lipocine To Announce Phase 3 Data For LPCN 1154 Treatment For Postpartum Depression On May 26

CORRECTION: Lipocine Q1 EPS $(0.54) Misses $(0.48) Estimate, Sales $119.397K Miss $162.500K Estimate

Lipocine Q1 EPS $(0.54) Misses $(0.48) Estimate, Sales $119.397M Beat $162.500K Estimate

Lipocine Appoints R. Dana Ono As Chairman Of The Board On April 20, 2026

What's Going On With Lipocine Stock On Monday?

HC Wainwright & Co. Downgrades Lipocine to Neutral

Lipocine shares are trading lower after the company's LPCN 1154 missed its Phase 3 primary endpoint in postpartum depression.

Lipocine shares are trading lower after the company's LPCN 1154 missed its Phase 3 primary endpoint in postpartum depression.

Lipocine Stock Plunges After LPCN 1154 Misses Phase 3 Primary Endpoint

Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times

Lipocine's LPCN 1154 Misses Phase 3 Primary Endpoint in Postpartum Depression; Shows Early Efficacy Signals In Patients With Prior Psychiatric History And Maintains Favorable Safety Profile

Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News Pending

Lipocine Files For Common Stock Offering Of Up To $50M

Lipocine Announces Last Patient Completes Final Study Visit In Phase 3 Clinical Trial For Oral Post-Partum Depression Treatment Brexanolone

HC Wainwright & Co. Maintains Buy on Lipocine, Raises Price Target to $15

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Completes Enrollment, Patient Dosing In Its Phase 3 Clinical Study Of LPCN 1154 To Treat Postpartum Depression

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Completes Scheduled Independent Data Safety Monitoring Board Review Of Ongoing Phase 3 Clinical Trial evaluating LPCN 1154 For Rapid Relief Treatment Of PPD.

Lipocine Granted U.S. Patent For Hydroxyprogesterone Caproate Compositions And Methods Of Use In Preventing Preterm Birth